Surmodics, Inc. (SRDX) Earnings History
Annual and quarterly earnings data from 1998 to 2024
Loading earnings history...
SRDX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SRDX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 73.8% | -4.5% | -9.2% |
| 2023 | 46.0% | 3.9% | -1.2% |
| 2022 | 29.0% | -22.1% | -27.3% |
| 2021 | 39.2% | 6.4% | 4.0% |
| 2020 | 30.9% | -1.3% | 1.2% |
Download Data
Export SRDX earnings history in CSV or JSON format
Free sign-in required to download data
Surmodics, Inc. (SRDX) Earnings Overview
As of May 8, 2026, Surmodics, Inc. (SRDX) reported trailing twelve-month net income of -$18M, reflecting -645.5% year-over-year growth. The company earned $-1.23 per diluted share over the past four quarters, with a net profit margin of -9.2%.
Looking at the long-term picture, SRDX's historical earnings data spans multiple years. The company achieved its highest annual net income of $38M in fiscal 2009.
Surmodics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), ATRC (-$5M net income, -2.1% margin), ANGO (-$28M net income, -11.6% margin), SRDX has outperformed on profitability metrics. Compare SRDX vs NVCR →
SRDX Earnings vs Peers
Earnings metrics vs comparable public companies
SRDX Historical Earnings Data (1998–2024)
27 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$12M | -651.4% | -$6M | $-0.82 | -9.2% | -4.5% |
| 2023 | -$2M | +94.4% | $5M | $-0.11 | -1.2% | 3.9% |
| 2022 | -$27M | -743.7% | -$22M | $-1.96 | -27.3% | -22.1% |
| 2021 | $4M | +277.3% | $7M | $0.30 | 4.0% | 6.4% |
| 2020 | $1M | -85.2% | -$1M | $0.08 | 1.2% | -1.3% |
| 2019 | $8M | +270.3% | $6M | $0.55 | 7.6% | 6.5% |
| 2018 | -$4M | -213.5% | -$9M | $-0.34 | -5.5% | -10.8% |
| 2017 | $4M | -60.7% | $7M | $0.29 | 5.4% | 9.7% |
| 2016 | $10M | -25.7% | $17M | $0.76 | 14.0% | 23.6% |
| 2015 | $13M | +11.8% | $19M | $1.01 | 21.7% | 30.8% |
See SRDX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SRDX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SRDX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSRDX — Frequently Asked Questions
Quick answers to the most common questions about buying SRDX stock.
Is SRDX growing earnings?
SRDX EPS fell to $-1.23, with earnings declining -645.5%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-18M.
What are SRDX's profit margins?
Surmodics, Inc. net margin is -9.2%, with operating margin at -4.5%. Below-average margins reflect competitive or cost pressures.
How consistent are SRDX's earnings?
SRDX earnings data spans 1998-2024. The declining earnings trend is -645.5% YoY. Historical data enables comparison across business cycles.